(Q47965497)

English

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine? (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

0 references

1 reference

based on heuristic

inferred from title

author name string

Goadsby PJ

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

Hoskin KL

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

43

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

711-718

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

The mode of action of sumatriptan is vascular? A debate

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Naratriptan: biological profile in animal models relevant to migraine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Rizatriptan has central antinociceptive effects against durally evoked responses

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Innervation of the posterior fossa dura of the cat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

The sensory representation of the dura mater in the trigeminal ganglion of the cat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Rationale for the use of 5-HT1-like agonists in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

5-HT1-like receptor mediated changes in porcine carotid haemodynamics: are 5-HT1D receptors involved?

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Central serotonergic nerves project to the pial vessels of the brain.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Serotonin in the regulation of brain microcirculation

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Probable involvement of serotonin in the increased permeability of the blood-brain barrier by forced swimming. An experimental study using Evans blue and 131I-sodium tracers in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Impairment of blood-brain barrier function by serotonin induces desynchronization of spontaneous cerebral cortical activity: experimental observations in the anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Migraine and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Brain stem activation in spontaneous human migraine attacks

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Oral sumatriptan in acute migraine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430605

21 January 2018

Identifiers

10.1002/ANA.410430605

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/9629840

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47965497&oldid=2072293939"